Oaktree Acquisition Corp. III Life Sciences (OACC) Stock Chart & Stock Price History $10.43 -0.01 (-0.10%) As of 07/18/2025 03:32 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock Oaktree Acquisition Corp. III Life Sciences Stock Price Performance The Oaktree Acquisition Corp. III Life Sciences (OACC) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 1.51%, reflecting recent market activity. As of the latest close, Oaktree Acquisition Corp. III Life Sciences traded at $10.43 with a market cap of $233.84 million and volume of 16,410 shares. Receive OACC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oaktree Acquisition Corp. III Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.19%1 Month Performance-1.51%3 Month Performance+3.17% OACC Stock Chart for Sunday, July, 20, 2025 OACC Chart by TradingView Oaktree Acquisition Corp. III Life Sciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/18/2025$10.44$10.43-0.10%$10.44$10.4116,410 shs$233.84 million07/17/2025$10.42$10.44+0.19%$10.44$10.4029,901 shs$234.07 million07/16/2025$10.45$10.42-0.29%$10.44$10.4210,624 shs$233.67 million07/15/2025$10.44$10.45+0.10%$10.47$10.351,302 shs$234.29 million07/14/2025$10.41$10.44+0.29%$10.44$10.419,679 shs$234.07 million07/11/2025$10.40$10.41+0.10%$10.44$10.3941,860 shs$233.39 million07/10/2025$10.42$10.40-0.19%$10.45$10.354,871 shs$233.22 million07/09/2025$10.45$10.42-0.29%$10.47$10.42436 shs$233.62 million07/08/2025$10.41$10.45+0.38%$10.45$10.4220,496 shs$234.29 million07/07/2025$10.44$10.41-0.29%$10.41$10.41181 shs$233.39 million Get the Latest News and Ratings for OACC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oaktree Acquisition Corp. III Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 07/04/2025$10.44$10.44$10.45$10.441,200 shs$234.07 million07/03/2025$10.45$10.44-0.10%$10.45$10.441,200 shs$234.07 million07/02/2025$10.46$10.45-0.10%$10.47$10.3839,783 shs$234.34 million07/01/2025$10.45$10.46+0.10%$10.49$10.4651,533 shs$234.51 million06/30/2025$10.49$10.45-0.41%$10.50$10.4523,222 shs$234.29 million06/27/2025$10.49$10.49$10.55$10.3869,010 shs$235.19 million06/26/2025$10.49$10.49$10.55$10.3869,010 shs$235.19 million06/25/2025$10.55$10.49-0.57%$10.55$10.45147,390 shs$235.19 million06/24/2025$10.56$10.55-0.09%$10.55$10.5510,159 shs$236.53 million06/23/2025$10.59$10.56-0.28%$10.57$10.5028,269 shs$236.81 million06/20/2025$10.59$10.59$10.59$10.5937 shs$237.43 million06/19/2025$10.59$10.59$10.59$10.5937 shs$237.43 million Related Companies Franklin BSP Realty Trust Stock Chart Orchid Island Capital Stock Chart NexPoint Residential Trust Stock Chart Patria Investments Stock Chart Noah Stock Chart Associated Capital Group Stock Chart Getty Images Stock Chart Tiga Acquisition Stock Chart Plymouth Industrial REIT Stock Chart Ares Acquisition Corporation II Stock Chart Receive OACC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oaktree Acquisition Corp. III Life Sciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OACC) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
